<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31408408</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>07</Month>
        <Day>15</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>12</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1557-8585</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>17</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Lymphatic research and biology</Title>
          <ISOAbbreviation>Lymphat Res Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Lipedema and Dercum's Disease: A New Application of Bioimpedance.</ArticleTitle>
        <Pagination>
          <StartPage>671</StartPage>
          <EndPage>679</EndPage>
          <MedlinePgn>671-679</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1089/lrb.2019.0011</ELocationID>
        <Abstract>
          <AbstractText><b><i>Background:</i></b> Lipedema and Dercum's disease (DD) are incompletely characterized adipose tissue diseases, and objective measures of disease profiles are needed to aid in differential diagnosis. We hypothesized that fluid properties, quantified as tissue water bioimpedance in the upper and lower extremities, differ regionally between these conditions. <b><i>Methods and Results:</i></b> Women (cumulative <i>n</i> = 156) with lipedema (<i>n</i> = 110), DD (<i>n</i> = 25), or without an adipose disease matched for age and body mass index to early stage lipedema patients (i.e., controls <i>n</i> = 21) were enrolled. Bioimpedance spectroscopy (BIS) was applied to measure impedance values in the arms and legs, indicative of extracellular water levels. Impedance values were recorded for each limb, as well as the leg-to-arm impedance ratio. Regression models were applied to evaluate hypothesized relationships between impedance and clinical indicators of disease (significance criteria: two-sided <i>p</i> &lt; 0.05). Higher extracellular water was indicated (i) in the legs of patients with higher compared with lower stages of lipedema (<i>p</i> = 0.03), (ii) in the leg-to-arm impedance ratio in patients with lipedema compared with patients with DD (<i>p</i> ≤ 0.001), and (iii) in the leg-to-arm impedance ratio in patients with stage 1 lipedema compared with controls (<i>p</i> ≤ 0.01). <b><i>Conclusion:</i></b> BIS is a noninvasive portable modality to assess tissue water, and this device is available in both specialized and nonspecialized centers. These findings support that regional bioimpedance measures may help to distinguish lipedema from DD, as well as to identify early stages of lipedema.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Crescenzi</LastName>
            <ForeName>Rachelle</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Donahue</LastName>
            <ForeName>Paula M C</ForeName>
            <Initials>PMC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Physical Medicine and Rehabilitation, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Dayani Center for Health and Wellness, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Weakley</LastName>
            <ForeName>Sandra</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Garza</LastName>
            <ForeName>Maria</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Donahue</LastName>
            <ForeName>Manus J</ForeName>
            <Initials>MJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Herbst</LastName>
            <ForeName>Karen L</ForeName>
            <Initials>KL</Initials>
            <AffiliationInfo>
              <Affiliation>TREAT Program, College of Medicine, University of Arizona, Tucson, Arizona.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Medicine, University of Arizona, Tucson, Arizona.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 NR015079</GrantID>
            <Acronym>NR</Acronym>
            <Agency>NINR NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>13</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Lymphat Res Biol</MedlineTA>
        <NlmUniqueID>101163587</NlmUniqueID>
        <ISSNLinking>1539-6851</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000274" MajorTopicYN="N">Adiposis Dolorosa</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017097" MajorTopicYN="Y">Electric Impedance</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D065134" MajorTopicYN="N">Lipedema</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D063189" MajorTopicYN="N">Symptom Assessment</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Dercum's disease</Keyword>
        <Keyword MajorTopicYN="Y">adiposis dolorosa</Keyword>
        <Keyword MajorTopicYN="Y">bioimpedance spectroscopy</Keyword>
        <Keyword MajorTopicYN="Y">lipedema</Keyword>
        <Keyword MajorTopicYN="Y">lipoedema</Keyword>
      </KeywordList>
      <CoiStatement>M.J.D. receives research-related support from Philips North America, is a paid consultant for Prana Biotechnology and Global Blood Therapeutics, and is the CEO of Biosight, LLC, which provides clinical trials consulting services.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31408408</ArticleId>
        <ArticleId IdType="pmc">PMC6919257</ArticleId>
        <ArticleId IdType="doi">10.1089/lrb.2019.0011</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Torre YS, Wadeea R, Rosas V, Herbst KL. 
Lipedema: Friend and foe. Horm Mol Biol Clin Investig
2018; 33:1–10</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5935449</ArticleId>
            <ArticleId IdType="pubmed">29522416</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Herbst KL.
Rare adipose disorders (RADs) masquerading as obesity. Acta Pharmacologica Sinica
2012; 33:155–172</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4010336</ArticleId>
            <ArticleId IdType="pubmed">22301856</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Szél E, Kemény L, Groma G, Szolnoky G. 
Pathophysiological dilemmas of lipedema. Med Hypotheses
2014; 83:599–606</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25200646</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Meier-vollrath I, Schmeller W. 
Lipodem—aktueller stand, neue Perspektiven. Lipoedema—current status, new perspectives. J Dtsch Dermatol Ges
2004; 2004(Band 2):181–186</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16281634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Beltran K, Herbst KL. 
Differentiating lipedema and Dercum's disease. Int J Obes (Lond)
2017; 41:240–245</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27857136</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Stemmer R.
[A clinical symptom for the early and differential diagnosis of lymphedema]. Vasa
1976; 5:261–262</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">969857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Beighton P, Grahame R, Bird H. 
Assessment of hypermobility. In: Beighton P, Grahame R, Bird H, eds. Hypermobility of Joints. 4th ed
London: Springer-Verlag; 2012:11–26</Citation>
        </Reference>
        <Reference>
          <Citation>
Cornish B, Ward LC. 
Data analysis in multiple-frequency bioelectrical impedance analysis. Physiol Meas
1998; 19:275–283</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9626691</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cornish B.
Bioimpedance analysis: Scientific background. Lymphat Res Biol
2006; 4:47–50</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16569208</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Czerniec SA, Ward LC, Refshauge KM, et al. . 
Assessment of breast cancer-related arm lymphedema—Comparison of physical measurement methods and self-report. Cancer Invest
2010; 28:54–62</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19916749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cornish BH, Chapman M, Hirst C, et al. . 
Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology
2001; 34:2–11</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11307661</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ridner SH, Shih YC, Doersam JK, Rhoten BA, Schultze BS, Dietrich MS. 
A pilot randomized trial evaluating lymphedema self-measurement with bioelectrical impedance, self-care adherence, and health outcomes. Lymphat Res Biol
2014; 12:258–266</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4267706</ArticleId>
            <ArticleId IdType="pubmed">25412401</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
El-Kateb S, Davenport A. 
Changes in hydration following haemodialysis estimated with bioimpedance spectroscopy. Nephrology (Carlton)
2016; 21:410–415</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26436338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Melchart D, Low P, Wuhr E, Kehl V, Weidenhammer W. 
Effects of a tailored lifestyle self-management intervention (TALENT) study on weight reduction: A randomized controlled trial. Diabetes Metab Syndr Obes
2017; 10:235–245</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5484507</ArticleId>
            <ArticleId IdType="pubmed">28684917</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Baron S, Courbebaisse M, Lepicard EM, Friedlander G. 
Assessment of hydration status in a large population. Br J Nutr
2015; 113:147–158</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25418739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Tsigos C, Stefanaki C, Lambrou GI, Boschiero D, Chrousos GP. 
Stress and inflammatory biomarkers and symptoms are associated with bioimpedance measures. Eur J Clin Invest
2015; 45:126–134</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25431352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Montalvo R, Bernabe-Ortiz A, Kirwan DE, Gilman RH. 
Bioimpedance markers and tuberculosis outcome among HIV-infected patients. Afr J Infect Dis
2018; 12:47–54</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6085739</ArticleId>
            <ArticleId IdType="pubmed">30109286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sung RY, Lau P, Yu CW, Lam PK, Nelson Ea. 
Measurement of body fat using leg to leg bioimpedance. Arch Dis Child
2001; 85:263–267</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1718893</ArticleId>
            <ArticleId IdType="pubmed">11517118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Pietrobelli A, Rubiano F, St-Onge M-P, Heymsfield SB. 
New bioimpedance analysis system: Improved phenotyping with whole-body analysis. Eur J Clin Nutr
2004; 58:1479–1484</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15138459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gaw R, Box R, Cornish B. 
Bioimpedance in the assessment of unilateral lymphedema of a limb: The optimal frequency. Lymphat Res Biol
2011; 9:93–99</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21688978</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Blaney JM, McCollum G, Lorimer J, Bradley J, Kennedy R, Rankin JP. 
Prospective surveillance of breast cancer-related lymphoedema in the first-year post-surgery: Feasibility and comparison of screening measures. Support Care Cancer
2015; 23:1549–1559</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25398360</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ward LC, Dylke E, Czerniec S, Isenring E, Kilbreath SL. 
Reference ranges for assessment of unilateral lymphedema in legs by bioelectrical impedance spectroscopy. Lymphat Res Biol
2011; 9:43–46</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21417766</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ward LC, Dylke E, Czerniec S, Isenring E, Kilbreath SL. 
Confirmation of the reference impedance ratios used for assessment of breast cancer-related lymphedema by bioelectrical impedance spectroscopy. Lymphat Res Biol
2011; 9:47–51</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21417767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ridner SH, Dietrich MS, Deng J, Bonner CM, Kidd N. 
Bioelectrical impedance for detecting upper limb lymphedema in nonlaboratory settings. Lymphat Res Biol
2009; 7:11–15</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2678847</ArticleId>
            <ArticleId IdType="pubmed">19231915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mayrovitz HN, Fasen M, Spagna P, Wong J. 
Role of handedness on forearm skin tissue dielectric constant (TDC) in relation to detection of early-stage breast cancer-related lymphedema. Clin Physiol Funct Imaging
2018; 38:670–675</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28795491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mayrovitz HN, Weingrad DN, Lopez L. 
Tissue dielectric constant (TDC) as an index of skin water in women with and without breast cancer: Upper limb assessment via a self-contained compact measurement device. Lymphology
2016; 49:27–35</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29906062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Donahue PM, Crescenzi R, Scott AO, et al. . 
Bilateral changes in deep tissue environment after manual lymphatic drainage in patients with breast cancer treatment-related lymphedema. Lymphat Res Biol
2017; 15:45–56</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5369395</ArticleId>
            <ArticleId IdType="pubmed">28323572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Tiwari A, Cheng K, Button M, Myint F, Hamilton G. 
Differential diagnosis, investigation, and current treatment of lower limb lymphedema. Arch Surg
2003; 138:152–161</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12578410</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Jaffrin MY, Morel H. 
Body fluid volumes measurements by impedance: A review of bioimpedance spectroscopy (BIS) and bioimpedance analysis (BIA) methods. Med Eng Phys
2008; 30:1257–1269</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18676172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Crescenzi R, Marton A, Donahue PMC, et al. . 
Tissue sodium content is elevated in the skin and subcutaneous adipose tissue in women with lipedema. Obesity (Silver Spring)
2018; 26:310–317</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5783748</ArticleId>
            <ArticleId IdType="pubmed">29280322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rasmussen JC, Herbst KL, Aldrich MB, et al. . 
An abnormal lymphatic phenotype is associated with subcutaneous adipose tissue deposits in Dercum's disease. Obesity (Silver Spring)
2014; 22:2186–2192</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4180796</ArticleId>
            <ArticleId IdType="pubmed">25044620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Herbst K, Mirkovskaya L, Bharhagava A, Chava Y, Te CH. 
Lipedema fat and signs and symptoms of illness, increase with advancing stage. Arch Med
2015; 7:1–8</Citation>
        </Reference>
        <Reference>
          <Citation>
Fife CE, Maus Ea, Carter MJ. 
Lipedema: A frequently misdiagnosed and misunderstood fatty deposition syndrome. Adv Skin Wound Care
2010; 23:81–92; quiz 93–94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20087075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Fetzer A, Fetzer S. L ipoedema UK Big Survey 2014 Research Report 2016:1–8. www.lipoedema.co.uk/lipoedema-uks-big-survey (Accessed May17, 2017)</Citation>
        </Reference>
        <Reference>
          <Citation>
Pouwels S, Huisman S, Smelt HJM, Said M, Smulders JF. 
Lipoedema in patients after bariatric surgery: Report of two cases and review of literature. Clin Obes
2018; 8:147–150</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29372593</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bast JH, Ahmed L, Engdahl R. 
Lipedema in patients after bariatric surgery. Surg Obes Relat Dis
2016; 12:1131–1132</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27317598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Iivarinen JT, Korhonen RK, Julkunen P, Jurvelin JS. 
Experimental and computational analysis of soft tissue mechanical response under negative pressure in forearm. Skin Res Technol
2013; 19:e356–e365</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22650760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ibarra M, Eekema A, Ussery C, Neuhardt D, Garby K, Herbst KL. 
Subcutaneous adipose tissue therapy reduces fat by dual X-ray absorptiometry scan and improves tissue structure by ultrasound in women with lipoedema and Dercum disease. Clin Obes
2018; 8:398–406</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30248251</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Herbst KL, Ussery C, Eekema A. 
Pilot study: Whole body manual subcutaneous adipose tissue (SAT) therapy improved pain and SAT structure in women with lipedema. Horm Mol Biol Clin Investig
2017; 33:1–12</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28930626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Granzow JW.
Lymphedema surgery: The current state of the art. Clin Exp Metastasis
2018; 35:553–558</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29980891</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ghazala S, Bilal J, Ross E, Riaz IB, Kalb B, Herbst KL. 
Low-dose d-amphetamine induced regression of liver fat deposits in Dercum disease. Am J Med
2018; 131:705–708</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29355511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Tian W, Rockson SG, Jiang X, et al. . 
Leukotriene B4 antagonism ameliorates experimental lymphedema. Sci Transl Med
2017; 9:pii: </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28490670</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Boyages J, Kastanias K, Koelmeyer LA, et al. . 
Liposuction for advanced lymphedema: A multidisciplinary approach for complete reduction of arm and leg swelling. Ann Surg Oncol
2015; 22(Suppl. 3):S1263–S1270</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4686553</ArticleId>
            <ArticleId IdType="pubmed">26122375</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
